Literature DB >> 10529509

wt1 gene expression in childhood leukemias.

E Niegemann1, S Wehner, B Kornhuber, D Schwabe, U Ebener.   

Abstract

The expression of the Wilms' tumor gene (wt1) was detected in various tissues during embryonic development. Mutations in the wt1 gene probably play an important role in certain tumors, e.g. the Wilms' tumor. Furthermore the expression of wt1 gene was found in some human leukemias. In the present study we investigated the expression of wt1 gene in several types of childhood leukemia by reverse transcriptase-polymerase chain reaction. Bone marrow or peripheral blood of 61 pediatric patients (48 at initial diagnosis, 13 at first or second relapse) were analyzed. wt1 gene expression was detected in 35/48 patients (73%) with newly diagnosed leukemias and in 12/13 cases (92%) who had suffered from relapse. The expression levels were higher for AML than for ALL. The frequency of wt1 expression in different subtypes of acute leukemia was compared with results found in adult patients. Our results show that the frequency of wt1 gene expression in acute childhood leukemias is similar to previous data reported for adults.

Entities:  

Mesh:

Year:  1999        PMID: 10529509     DOI: 10.1159/000040973

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  7 in total

Review 1.  Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trials.

Authors:  Ann Van Driessche; Zwi N Berneman; Viggo F I Van Tendeloo
Journal:  Oncologist       Date:  2012-01-30

Review 2.  Translational mini-review series on vaccines: Peptide vaccines for myeloid leukaemias.

Authors:  A J Barrett; K Rezvani
Journal:  Clin Exp Immunol       Date:  2007-05       Impact factor: 4.330

3.  Mechanisms of leukemia resistance to antibody dependent cellular cytotoxicity.

Authors:  Leonid Dubrovsky; Elliott Joseph Brea; Dmitry Pankov; Emily Casey; Tao Dao; Cheng Liu; David A Scheinberg
Journal:  Oncoimmunology       Date:  2016-08-03       Impact factor: 8.110

4.  Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.

Authors:  Katayoun Rezvani; Agnes S M Yong; Stephan Mielke; Bipin N Savani; Laura Musse; Jeanine Superata; Behnam Jafarpour; Carol Boss; A John Barrett
Journal:  Blood       Date:  2007-09-17       Impact factor: 22.113

5.  A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias.

Authors:  Leonid Dubrovsky; Dmitry Pankov; Elliott Joseph Brea; Tao Dao; Andrew Scott; Su Yan; Richard J O'Reilly; Cheng Liu; David A Scheinberg
Journal:  Blood       Date:  2014-04-10       Impact factor: 22.113

6.  Preferentially Expressed Antigen of Melanoma (PRAME) and Wilms' Tumor 1 (WT 1) Genes Expression in Childhood Acute Lymphoblastic Leukemia, Prognostic Role and Correlation with Survival.

Authors:  Engy El Khateeb; Dalia Morgan
Journal:  Open Access Maced J Med Sci       Date:  2014-12-08

7.  Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia.

Authors:  Katayoun Rezvani; Agnes S M Yong; Bipin N Savani; Stephan Mielke; Keyvan Keyvanfar; Emma Gostick; David A Price; Daniel C Douek; A John Barrett
Journal:  Blood       Date:  2007-05-15       Impact factor: 22.113

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.